-
Current Practices and Attitudes of Cardiac Nurses Regarding Cognitive Screening in Patients With Acute Coronary Syndrome Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-11 Emma Zhao MN, Nicole Lowres PhD, Jacqueline Bloomfield PhD, Joseph Weddell BSc, Geoffrey Tofler PhD, Robyn Gallagher PhD
Cognitive impairment (CI) is common in patients with acute coronary syndrome (ACS) but is often undetected and may affect recovery and secondary prevention uptake. Nurses play a crucial role providing care for patients with ACS and promoting secondary prevention. This study aimed to explore current nursing practices and barriers regarding CI screening in patients with ACS. Cardiac nurses were recruited
-
Giant Right Atrial Myxoma – An Unusual Cause of Dyspnoea Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-10 Angiza Shahim MD, Torbjörn Ivert MD PhD, Magnus Dalén MD PhD
-
Palliative Care Utilisation and Outcomes in Patients Admitted for Heart Failure in a Victorian Healthcare Service Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-08 Sylvia Ye MBBS MClinRes, Cathy Corbett MBChB FRACP FAChPM, Adelaide S.M. Dennis MD PhD, Dylan Jape MD, Hitesh Patel MBBS PhD, Dominica Zentner MBBS FRACP PhD, Ingrid Hopper MBBS PhD
Heart failure (HF) has high mortality and healthcare utilisation. It has a complex and unpredictable trajectory, which is often interpreted as a barrier to guideline recommended early integration of palliative care (PC). In particular, lack of referral criteria and misconceptions around PC affect inpatient specialist PC referrals. The main objective was to characterise the pattern and predictors of
-
Prolonged Non-Steroidal Anti-Inflammatory Drug Exposure After Pleurodesis Increases Pneumothorax Recurrence: A Retrospective Cohort Study Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-08 John D.L. Brookes MBBS MSc, Andrew D. Cochrane MBBS MSurgEd FRACS, Julian A. Smith MBMS MSurgEd FRACS
The use of non-steroidal anti-inflammatory drugs (NSAID) in patients undergoing pleurodesis remains controversial. Although many surgeons are comfortable prescribing NSAIDs post-operatively, some oppose this practice due to concerns of suppressing the inflammatory response and quality of pleurodesis. Only a small body of inconsistent publications exists with respect to guiding therapy in this common
-
Optimal Conduit Diameter Selection in Coronary Bypass Grafting Using Saphenous Vein Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-07 Malgorzata (Maggie) Szpytma MD, Robert A. Baker PhD CCP, Damian Gimpel MBBS MMed(Surg), Richard F. Newland BSc CCP, David G. Lance FRACS, Gregory D. Rice FRACS, Gareth Crouch FRACS, Jayme S. Bennetts FRACS
Predictors of long-term saphenous vein graft (SVG) patency following coronary artery bypass grafting (CABG) include harvesting technique, degree of proximal coronary stenosis, and target vessel diameter and runoff. The objective of this study was to evaluate the association between vein graft diameter and long-term survival. Patients undergoing primary CABG (2000–2017) at Flinders Medical Centre, Adelaide
-
Cultivating Competency in Cardiac Sonography: Aligning Entrustable Professional Activities With Industry Expectations Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-07 Rebecca Perry PhD, Anthony Forshaw, Jessie Childs PhD, Deanne Chester, Christopher Edwards PhD
Echocardiography education involves the teaching and assessment of multiple competencies to ensure work-ready graduates. To connect these competency standards to professional practice, it is important that the industry expectation around specific entrustable professional activities (EPAs) is determined. In Australia, echocardiography examinations are eligible for Medicare reimbursement when performed
-
Determining the Optimal Methodology for Identifying Incident Stroke Deaths Using Administrative Datasets Within Australia Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-07 Anna H. Balabanski MBBS PhD, Lee Nedkoff PhD, Amanda G. Thrift PhD, Timothy J. Kleinig MBBS PhD, Alex Brown PhD, Odette Pearson PhD, Steven Guthridge FAFPHM, Angela Dos Santos MBBS, Judith M. Katzenellenbogen PhD
Quantifying stroke incidence and mortality is crucial for disease surveillance and health system planning. Administrative data offer a cost-effective alternative to “gold standard” population-based studies. However, the optimal methodology for establishing stroke deaths from administrative data remains unclear. We aimed to determine the optimal method for identifying stroke-related deaths in administrative
-
Comparison of Characteristics and Outcomes in Patients With Acute Decompensated Heart Failure Admitted Under General Medicine and Cardiology Units Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-07 Elizabeth Suo MD, Andrea Driscoll PhD, Diem Dinh PhD, Angela Brennan CCRN, David M. Kaye MBBS PhD, Dion Stub MBBS PhD, Jeffrey Lefkovits MBBS PhD, Christopher M. Reid MBBS PhD, Ingrid Hopper MBBS PhD
Acute decompensated heart failure (ADHF) is a leading cause of cardiovascular disease hospitalisations associated with significant morbidity and mortality. In hospitals, HF patients are typically managed by cardiology or physician teams, with differences in patient demographics and clinical outcomes. This study utilises contemporary HF registry data to compare patient characteristics and outcomes in
-
The Role of Hereditary Thrombophilia Testing in Management of First-Time Pulmonary Embolism Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-07 Sophie Sohval MD, Leonard Naymagon MD
Hereditary thrombophilia (HT) testing is frequently conducted during the evaluation of patients with pulmonary embolism (PE). However, the utility of routine HT testing in this setting is unclear. We sought to assess the association of HT with risk of recurrent venous thromboembolism (VTE) following first-time PE. We conducted a multi-hospital retrospective study. 290 patients with a first-time PE
-
Cardiogenic Shock Prior to Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction: Outcomes and Predictors of Mortality (ANZACS-QI 73) Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-07 Kyu Hyun Lee MBChB, Wil Harrison MBChB, Kok Lam Chow MBChB, Mildred Lee BTech MSc, Andrew J. Kerr MBChB
Cardiogenic shock (CS) is a serious complication of acute myocardial infarction (MI) and is associated with significant mortality. We describe a contemporary, real-world cohort of patients with ST-elevation MI (STEMI) and CS, including 30-day mortality and clinically relevant predictors of mortality. All patients presenting with STEMI who were treated with percutaneous coronary intervention (PCI) in
-
Cardiotoxicity in Oncology Guidelines: Discrepancies Do Matter Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-06 Sean Tan MBBS, Zainel Kader MD, Daphne Day MBBS, Daniel Chen BMed, Stephen J. Nicholls MBBS PhD, Satish Ramkumar MBBS PhD
-
Self-Apposing Stents in Coronary Chronic Total Occlusions: A Pilot Study Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-05 Ahmed Elborae MD MRCP, Mohamed Hassan MD FACC, Mohammed Abdel Meguid MD, Karim Bakry MD, Ahmad Samir MD, Emmanouil Brilakis MD PhD, Hossam Kandil MD, Ahmed ElGuindy MD FRCP FSCAI
This pilot study assessed the 12-month angiographic and clinical outcomes of self-apposing (SA) stents in patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Self-apposing (SA) stents may decrease incomplete strut apposition and stent strut coverage that are common after CTO PCI. We compared 20 patients who underwent CTO PCI using SA drug-eluting stents (DESs)
-
Peer Support and Cardiovascular Health: The Heart Foundation’s MyHeart MyLife Online Support Community Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-05 Dannii Dougherty BPhysio (Hons) PhD (Medicine), Natalie Raffoul BPharm (Hons) GradCertPharmMed MHM, Vanessa Poulsen BNg BHlthSc GradDipNg(Cardiac)
-
Shifting Perspective: Moving from Characterisation to Implementation of New Models of Care to Reduce Healthcare Burden due to Atrial Fibrillation Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-05 Celine Gallagher PhD, Christopher X. Wong MBBS MPH PhD, Dennis H. Lau MBBS PhD
-
Cardiac Resynchronisation Therapy: How Medicare Criteria Might Inadvertently Promote Disparate Healthcare Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-05 Laura Roccisano MClinEpi, Aleksandr Voskoboinik MBBS PhD, Justin Mariani MBBS PhD, Thomas H. Marwick MBBS PhD, Hitesh C. Patel MBBS PhD
-
Towards a Unified Rheumatic Heart Disease Imaging Dataset Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-05 Sarah Howson MD, Shaun Evans MD, Andrew E.C. Booth MD, Stephen Bacchi MBBS PhD, Aashray Gupta MBBS MS, Joshua Kovoor MBBS MS, Brandon Stretton MBBS, Adam Nelson FRACP PhD, Pramesh Kovoor FRACP PhD
-
Clinical Effectiveness and Utilisation of Cardiac Rehabilitation After Hospital Discharge: Data Linkage Analysis of 84,064 Eligible Discharged Patients (2016–2021) Heart Lung. Circ. (IF 2.6) Pub Date : 2024-03-05 Alline Beleigoli MD PhD, Jonathon Foote BN, Lemlem G. Gebremichael PhD, Norma B. Bulamu PhD, Carolyn Astley BN PhD, Wendy Keech MPH, Rosanna Tavella PhD, Aarti Gulyani MSc, Katie Nesbitt MN, Maria Alejandra Pinero de Plaza PhD, Joyce S. Ramos PhD, Marie Ludlow PhD, Stephen J. Nicholls MD PhD, Derek P. Chew MD PhD, John Beltrame MD PhD, Robyn A. Clark PhD
Despite the highest levels of evidence on cardiac rehabilitation (CR) effectiveness, its translation into practice is compromised by low participation. This study aimed to investigate CR utilisation and effectiveness in South Australia. This retrospective cohort study used data linkage of clinical and administrative databases from 2016 to 2021 to assess the association between CR utilisation (no CR
-
Impact of the New Definition of Pulmonary Hypertension on the Prevalence of Primary Graft Dysfunction in Lung Transplant Recipients Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-29 Víctor M. Mora-Cuesta MD PhD, Amaya Martínez-Meñaca MD, David Iturbe-Fernández MD, Sandra Tello-Mena MD, Sheila Izquierdo-Cuervo MD, Tamara García-Camarero MD PhD, Aritz Gil-Ongay MD PhD, Laura Sánchez-Moreno MD PhD, Pilar Alonso-Lecue PhD, Sara Naranjo-Gozalo MD PhD, José M. Cifrián-Martínez MD PhD
Pulmonary hypertension (PH) secondary to lung disease (Group-3 PH) is the second leading cause of PH. The role of PH as a risk factor for primary graft dysfunction (PGD) following lung transplant (LT) is controversial. To assess the impact that the new definition of PH had on the prevalence of PH in patients with advanced lung disease—candidate for LT, and its association with the occurrence of PGD
-
The Effect of Angiotensin Receptor Blockers on In-Stent Restenosis After Stent Implantation: A Meta-Analysis Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-28 Cui Zhao, Kai Hou, Lu Cao, Jixiang Wang
Angiotensin receptor blockers (ARBs) have been shown to inhibit restenosis in vitro and in vivo, but the evidence found in humans is inconsistent. This study aimed to evaluate the effectiveness of ARBs in preventing in-stent restenosis after percutaneous coronary intervention (PCI). Databases including the Cochrane Library, MEDLINE, Web of Science, EMBASE, and CNKI were searched to collect randomised
-
Thoracoscopic Management of Chylothorax by Application of a Fibrin Sealant Patch Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-26 Alfonso Fiorelli, Francesca Capasso, Gaetana Messina, Giovanni Natale
Thoracic duct ligation is a demanding procedure when the chyle leak and/or the duct itself are not identified. This report is of a new procedure using thoracoscopic closure of the chyle leak by application of a fibrin sealant patch. This strategy was successfully applied for closing (i) a small fistula due to a postoperative lesion of the lymphatic tributary vessels in one case, and (ii) a large fistula
-
A Mixed Methods Study Exploring Patient Perspectives and Outcome Measures From Not Fasting Before Cardiac Catheterisation Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-24 Tristin L. Kimpton, Mark Webster, Kim Ward
This study aimed to describe the patient experience and incidence of adverse events in unfasted patients undergoing coronary angiography and angioplasty. In addition, to identify any association between duration of fasting and adverse events. Historically, patients were fasted before elective cardiac catheterisation. Routine fasting was not evidence-based, and many centres, including our unit, have
-
Surgical Management of Anomalous Right Coronary Artery in the Adult: Technique and Case Series Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-24 Fabio Ramponi, Omar Lattouf, Amber Jin, John D. Puskas
The management of adult patients with anomalous aortic origin of the right coronary artery (ARCA) from the left aortic sinus poses important challenges. The presence of symptoms or documented ischaemia, the anatomical characteristics of the ostium, and the course of the coronary determine decision-making. A retrospective review was performed of all cases of surgical management of ARCA at a single centre
-
Letter to the Editor: Enhancing Reporting Standards in Aortic Dissection: Integrating Coronary Arteries into Aortic Zonal Division, regarding “TEM Classification of Aortic Dissection—The Evolving Scoring System: A Literature Review” by Ramesh et al., Heart Lung Circ. 2024;33(1):17–22. Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-23 Andrei M. Belyaev
-
Utilisation of Chronic Disease and Mental Health Management Services and Cardioprotective Medication Prescriptions in Primary Care for Patients With Cardiovascular Diseases and Cancer: A Cross-Sectional Study Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-23 Qiang Tu, Karice Hyun, Nashid Hafiz, Andrew Knight, Charlotte Hespe, Clara K. Chow, Tom Briffa, Robyn Gallagher, Christopher M. Reid, David L. Hare, Nicholas Zwar, Mark Woodward, Stephen Jan, Emily R. Atkins, Tracey-Lea Laba, Elizabeth Halcomb, Matthew Hollings, Anna Singleton, Tim Usherwood, Julie Redfern
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among cancer survivors. Mental health is considered an important risk factor affecting the treatment of cardiovascular disease. However, little is known about the use of secondary prevention strategies for CVD in patients with both cancer and CVD. This study aimed to compare the utilisation of primary care chronic disease management
-
Structured Weaning From the Impella Left Ventricular Micro-Axial Pump in Acute Myocardial Infarction With Cardiogenic Shock and Protected Percutaneous Coronary Intervention: Experience From a Non-Cardiac Surgical Centre Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-22 Ryan J. Slack, Forbes McGain, Nicholas Cox, Craig French, Victoria Cheng, Dion Stub, Brian Zakhem, Fabien Dade, Jason E. Bloom, William Chan, Yang Yang
The Impella (Abiomed, Danvers, MA, USA) temporary percutaneous left ventricular assist device is increasingly used as mechanical circulatory support in patients with acute myocardial infarction–cardiogenic shock (AMICS) or those undergoing high-risk protected percutaneous coronary intervention (PCI). The optimal weaning regimen remains to be defined. We implemented a structured weaning protocol in
-
Modifiable and Non-Modifiable Risk Factors for Premature Coronary Heart Disease (PCHD): Systematic Review and Meta-Analysis Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-16 Adeel Khoja, Prabha H. Andraweera, Zohra S. Lassi, Zahra A. Padhani, Anna Ali, Mingyue Zheng, Maleesa M. Pathirana, Emily Aldridge, Melanie R. Wittwer, Debajyoti D. Chaudhuri, Rosanna Tavella, Margaret A. Arstall
We aimed to compare the prevalence of modifiable and non-modifiable coronary heart disease (CHD) risk factors among those with premature CHD and healthy individuals. PubMed, CINAHL, Embase, and Web of Science databases were searched (review protocol is registered in PROSPERO CRD42020173216). The quality of studies was assessed using the National Heart, Lung and Blood Institute tool for cross-sectional
-
Cancer Therapies and Cardiomyocyte Viability: Which Drugs are Directly Cardiotoxic? Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-15 Lohis Balachandran, Tatt Jhong Haw, Angeline Jia Wen Leong, Amanda J. Croft, Dongqing Chen, Conagh Kelly, Aaron L. Sverdlov, Doan T.M. Ngo
Increased cancer survivorship represents a remarkable achievement for modern medicine. Unfortunately, cancer treatments have inadvertently contributed to cardiovascular (CV) damage, significantly threatening the health and quality of life of patients living with, through and beyond cancer. Without understanding the mechanisms, including whether the cardiotoxicity is due to the direct or indirect effects
-
Recovery Rates of Diagnostic Cardiac Procedural Volume in Oceania 1 Year Into COVID-19: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID 2) Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-15 Anver Sethwala, Cole B. Hirschfeld, Patricia O'Sullivan, Mohamed Akbarally, John Younger, Niels Van Pelt, Michael Randazzo, Dora Lenturut-Katal, Joao V. Vitola, Rodrigo Cerci, Michelle C. Williams, Leslee J. Shaw, Ganesan Karthikeyan, Todd C. Villines, Sharmila Dorbala, Andrew D. Choi, Yosef A. Cohen, Eli Malkovskiy, Thomas N.B. Pascual, Yaroslav Pynda, Maurizio Dondi, Diana Paez, Andrew J. Einstein
The aim of this study was to assess the recovery rates of diagnostic cardiac procedure volumes in the Oceania Region, midway through the coronavirus disease 2019 (COVID-19) pandemic. A survey was performed comparing procedure volumes between March 2019 (pre-pandemic), April 2020 (during first wave of COVID-19 pandemic), and April 2021 (1 year into the COVID-19 pandemic). A total of 31 health care facilities
-
Robotic Assisted Percutaneous Coronary Intervention: Initial Australian Experience Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-15 James Leung, John French, James Xu, Hashim Kachwalla, Krishna Kaddapu, Tamer Badie, Christian Mussap, Rohan Rajaratnam, Dominic Leung, Sidney Lo, Craig Juergens
Robotic-assisted percutaneous coronary intervention (R-PCI) has been increasingly performed overseas. Initial observations have demonstrated its clinical efficacy and safety with additional potential benefits of more accurate lesion assessment and stent deployment, with reduced radiation exposure to operators and patients. However, data from randomised controlled trials or clinical experience from
-
Implementation of Patient Blood Management in Orthotopic Heart Transplants: A Single Centre Retrospective Observational Review Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-15 Jacob J. Rapier, Michael Daley, Susan E. Smith, Sean L. Goh, Swaroop Margale, Ian Smith, Bruce M. Thomson, Peter J. Tesar, Bronwyn L. Pearse
Blood transfusion in the perioperative cardiothoracic setting has accepted risks including deep sternal wound infection, increased intensive care unit length of stay, lung injury, and cost. It has an immunomodulatory effect which may cause allo-immunisation. This may influence long-term survival through immune-mediated factors. Targeting coagulation defects to reduce unnecessary or inappropriate transfusions
-
Efficacy of Guideline-Directed Medical Therapy in Heart Failure Patients With and Without Chronic Kidney Disease: A Meta-Analysis of 63,677 Patients Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-15 Kameron M. Clark, Faraz Mahboob, Jack Evans, Jessica H. Sun, Nelson Wang
Chronic kidney disease (CKD) coexists in up to 50% of heart failure (HF) patients, affecting both those with reduced ejection fraction (HFrEF) and those with preserved ejection fraction (HFpEF). Although the efficacy of several guideline-directed medical therapies (GDMT) has been well established, the treatment recommendations are similar for those patients with HF with and without CKD. We aimed to
-
Predicting Adverse Outcomes Following Catheter Ablation Treatment for Atrial Flutter/Fibrillation Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-15 Juan C. Quiroz, David Brieger, Louisa R. Jorm, Raymond W. Sy, Benjumin Hsu, Blanca Gallego
To develop prognostic survival models for predicting adverse outcomes after catheter ablation treatment for non-valvular atrial fibrillation (AF) and/or atrial flutter (AFL). We used a linked dataset including hospital administrative data, prescription medicine claims, emergency department presentations, and death registrations of patients in New South Wales, Australia. The cohort included patients
-
Low Mean Perfusion Pressure Indexed to Body Surface Area is a Powerful Predictor of Poor Outcomes After Heart Transplantation in Patients With High Pre-Transplant Venous Pressure: A Clinical Study With Physiological Insights From Mathematical Modelling of Biventricular Heart Failure Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-15 G. Rajagopalan, Komarakshi R. Balakrishnan, K.G. Suresh Rao, R. Ravi Kumar, Ramarathnam Krishna Kumar
The deleterious consequences of chronically elevated venous pressure in patients with profound right ventricular or biventricular dysfunction are well known, including renal and hepatic dysfunction, and volume overload. The only option for these patients, if they fail optimal medical treatment, is a heart transplant, as they are not candidates for left ventricular assist device therapy. Mean perfusion
-
-
Gender Differences in Coronary Artery Disease Severity and Revascularisation in Patients Referred for Coronary Angiography From Rural and Remote Western Australia Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-12 Nick S.R. Lan, Mikhail Alexander, Graham S. Hillis, Brendan M. McQuillan, Tom G. Briffa, Frank M. Sanfilippo, Girish Dwivedi, James M. Rankin, Abdul Rahman Ihdayhid
-
Delving Deeper into the Causes of Sudden Death in the Young—The Importance of Distinguishing “Signal” from “Noise” Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-12 Ashwin Bhaskaran, Saurabh Kumar
-
Quo Vadis Mitral Valve Repair? From a Definite French Correction (1983) to a Possible Australian Disconnection (2023) Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-12 John M. Alvarez
-
-
Letter to the Editor: An Update on Malpositioned Electrocardiographic Leads – The ‘Double Twist’ Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-12 Anver Sethwala, Harry G. Mond
-
Outcomes of Valvular Heart Disease—How Can We Close the Gap for Indigenous Patients? Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-12 Adam El-Gamel, Jai Raman
-
‘Seamless Transitions’ and Beyond on the Journey of Heart, Lung and Circulation Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-12 A. Robert Denniss, Salvatore Pepe
-
-
Walking Our Way to a Healthier Australia Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-12 Mistralle Brouillard, Elizabeth Calleja, Teresa Gadaleta, Kym Lang
-
Clinical Trajectories and Long-Term Outcomes of Alcoholic Versus Other Forms of Dilated Cardiomyopathy Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-09 Amanda Fernandes, Alan Manivannan, Morten Schou, Emil Fosbøl, Lars Køber, Finn Gustafsson, Gunnar H. Gislason, Christian Torp-Pedersen, Charlotte Andersson
Alcoholic cardiomyopathy (ACM) is a form of dilated cardiomyopathy (DCM) occurring secondary to long-standing heavy alcohol use and is associated with poor outcomes, but the cause-specific risks are insufficiently understood. Between 1997 and 2018, we identified all patients with a first diagnosis of ACM or DCM. The cumulative incidence of different causes of hospitalisation and mortality in the two
-
Integrating CardioOncology Across the Research Pipeline, Policy, and Practice in Australia—An Australian Cardiovascular Alliance Perspective Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-09 Anna C. Singleton, Julie Redfern, Abbey Diaz, Bogda Koczwara, Stephen J. Nicholls, Kazuaki Negishi, Andre La Gerche, David Playford, Rachel Conyers, Daniel A. Cehic, Gail Garvey, Trent D. Williams, Lee Hunt, Kerry Doyle, Gemma A. Figtree, Doan T.M. Ngo, Aaron L. Sverdlov, Mary Kavurma, Alex Pinto, Grant Drummond, Rebecca Ritchie, Peter Barlis, Peter Meikle, Alicia Jenkins, Chris Reid, Vincent Thijs
-
Australian National Standards of Care for Childhood-onset Heart Disease (CoHD Standards). 1st Edition Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-09 Gary F. Sholler AM MBBS FRACP, Lisa A. Selbie PhD, Mary Tallon BN MScN PhD, Jessica Keating BN MHA MPH, Julian Ayer MBBS PhD FRACP, Luke Burchill MBBS PhD FRACP, Michael M.H. Cheung MBChB MD FRACP, Rachael Cordina MBBS PhD FRACP, Evelyn Culnane BEd, Shakira Donovan BPsych MD, Lucas Eastaugh MBBS FRACP, Caitlin Elliott BNS PGDipNP, Jeffery Fletcher MBBS PhD FRACP, Robert N. Justo MBBS FRACP, Nadine
These first Australian National Standards of Care for Childhood-onset Heart Disease (CoHD Standards) have been developed to inform the healthcare requirements for CoHD services and enable all Australian patients, families and carers impacted by CoHD (paediatric CoHD and adult congenital heart disease [ACHD]) to live their best and healthiest lives.
-
Ebstein’s Anomaly of the Tricuspid Valve, Mitral Valve Prolapse and Left Ventricular Non-Compaction: A Triple Trouble Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-09 Swasthi S. Kumar, Sudipta Mondal, Saurav Banerjee
-
The Impact of Diabetes on Haemodynamic and Cardiometabolic Responses in Heart Failure With Preserved Ejection Fraction Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-09 Emilia Nan Tie, Shane Nanayakkara, Donna Vizi, Justin Mariani, David M. Kaye
Heart failure with preserved ejection (HFpEF) and diabetes mellitus (DM) commonly co-exist. However, it is unclear if DM modifies the haemodynamic and cardiometabolic phenotype in patients with HFpEF. We aimed to interrogate the haemodynamic and cardiometabolic effects of DM in HFpEF. We compared the haemodynamic and metabolic profiles of non-DM patients and patients with DM–HFpEF at rest and during
-
High Incidence of Cardiovascular Disease in Patients With Oesophageal Cancer—A Registry-Based Cohort Study Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-09 Mette Marie A. Søndergaard, Marianne Nordsmark, Kirsten M. Nielsen, Jan B. Valentin, Søren P. Johnsen, Steen H. Poulsen
The cardiovascular disease (CVD) burden among patients with oesophageal cancer (EC) treated with curative intent is unclear. To determine CVD incidence and all-cause mortality in patients with EC. Danish national health registries were used to identify patients diagnosed with primary EC between 2008 and 2018. Each EC patient was matched with ten individuals from the general population. The primary
-
National Standards of Care for Childhood-onset Heart Disease (CoHD)—A New Paradigm Whereby Healthcare Professionals, Governments and Consumers Work Together to Optimise Patient Care Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-09 D, a, v, i, d, , S, ., , C, e, l, e, r, m, a, j, e, r, , M, B, B, S, , D, S, c
-
Could Computed Tomography Coronary Angiography Replace Invasive Coronary Angiography as a First-Line Diagnostic Investigation in Suspected Acute Coronary Syndromes? A Decision-Analytic Model Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-08 Taylor Strube, Kristina Lambrakis, Kate George, Sam Lehman, Hossein Haji Ali Afzali, Derek P. Chew
The implementation of high-sensitivity cardiac troponin (hs-cTn) assays into clinical practice has resulted in the identification of a novel cohort of patients with modestly increased troponin concentrations. Subsequent increases in rates of coronary angiography have been observed, without significant increases in rates of coronary revascularisation. Computed tomography coronary angiography (CTCA)
-
Access to MRI in Patients With Cardiac Implantable Electronic Devices is Variable and an Issue in Australia Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-07 Nicholas Page, Karin Chia, David Brazier, Charlotte Manisty, Rebecca Kozor
This study aimed to characterise the level of access to magnetic resonance imaging (MRI) in Australian hospitals for patients with MR-conditional and non-MR-conditional cardiac implantable electronic devices (CIED), and to identify any barriers impeding this access. All Australian Tertiary Referral Public Hospitals (n=38) were surveyed with a mixed qualitative and quantitative questionnaire. Provision
-
Sex- and Age-Specific Differences in Risk Profiles and Early Outcomes in Adults With Acute Coronary Syndromes Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-07 Lee Nedkoff, Melanie Greenland, Karice Hyun, Jasmin P. Htun, Julie Redfern, Samantha Stiles, Frank Sanfilippo, Tom Briffa, Derek P. Chew, David Brieger
Adults <55 years comprise a quarter of all acute coronary syndromes (ACS) hospitalisations. There is a paucity of data characterising this group, particularly sex differences. This study aimed to compare the clinical and risk profile of patients with ACS aged <55 with older counterparts, and measure short-term outcomes by age and sex. The study population comprised patients with ACS enrolled in the
-
The Prevalence and Management of Atrial Fibrillation in New Zealand Māori Detected through an Abdominal Aortic Aneurysm Screening Program Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-06 Peter Sandiford, Katrina K. Poppe, Corina Grey, Robert Doughty, Erin Chambers, Kyu J. Kim, Andrew Hill, Karen Bartholomew
Atrial fibrillation (AF) screening was incorporated into an abdominal aortic aneurysm screening (AAA) program for New Zealand (NZ) Māori. AF screening was performed as an adjunct to AAA screening of Māori men aged 60–74 years and women aged 65–74 years registered with primary health care practices in Auckland, NZ. Pre-existing AF was determined through coded diagnoses or medications in the participant’s
-
Psoas Muscle Area as a Predictor of Transcatheter Aortic Valve Implantation Outcomes Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-06 Alexander P. Bate, Kyle B. Franke, Dylan R. Jones, Ramesh G. Chokka, Catherine Gibb, Jerrett K. Lau, Joseph Montarello, Peter J. Psaltis, Ross L. Roberts-Thomson
Frailty is a well-recognised predictor of outcomes after transcatheter aortic valve implantation (TAVI). Psoas muscle area (PMA) is a surrogate marker for sarcopaenia and is a validated assessment tool for frailty. The objective of this study was to examine frailty as a predictor of outcomes in TAVI patients and assess the prognostic usefulness of adding PMA to established frailty assessments. Frailty
-
The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction—A Systematic Review and Meta-Analysis of Randomised Controlled Trials Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-06 Vivian Y.J. Lee PhD, Lauren Houston PhD, Adam Perkovic MD, Jennifer Y. Barraclough PhD MD, Arianne Sweeting MD, Jie Yu PhD, Robert A. Fletcher MSc, Clare Arnott PhD MD
Heart failure with preserved ejection fraction (HFpEF) accounts for >50% of heart failure cases and is associated with significant morbidity and health system burden. To date, there have been limited treatment options proven to improve outcomes in these patients, with sodium glucose co-transporter 2 (SGLT2) inhibitors the first class of drug to demonstrate significant clinical benefits, including reductions
-
N-Terminal Pro-Brain Type Natriuretic Peptide Predicts Cardiovascular Events Independently of Arterial Stiffness, Assessed By Carotid-to-Femoral Pulse Wave Velocity, in Apparently Healthy Subjects Heart Lung. Circ. (IF 2.6) Pub Date : 2024-01-30 Charles Edward Frary, Marie Kofoed Blicher, Thomas Bastholm Olesen, Manan Pareek, Julie K.K. Vishram-Nielsen, Susanne Rasmussen, Michael Hecht Olsen
Aim This study aimed to evaluate whether N-terminal pro-brain natriuretic peptide (NT-proBNP) and carotid-to-femoral pulse wave velocity (PWV) carried independent prognostic value in predicting cardiovascular events in apparently healthy individuals beyond traditional risk factors. Methods A total of 1,872 participants aged 41, 51, 61, or 71 years from the MONItoring of trends and determinants in CArdiovascular
-
Ultrasound-mediated HGF Gene Microbubbles Mitigate Hyperkinetic Pulmonary Arterial Hypertension in Rabbits Heart Lung. Circ. (IF 2.6) Pub Date : 2024-02-01 Chuanzhen Liu PhD, Xin Lv BS, Xiangjin Kong BS, Lingwei Meng MD, Kaiming Wei BS, Ruyuan Wei MD, Mengmeng Tang MD, Jianhua Li PhD, Guangqing Cao PhD
-
Erratum to “Predicted Need for Atrial and Ventricular Pacing Per Indication Group in Patients With Dual-Chamber Pacemakers” [Heart Lung Circ. 32(5) (2023) 629-637] Heart Lung. Circ. (IF 2.6) Pub Date : 2024-01-30 Karel T.N. Breeman MD MSc, Leonard A. Dijkshoorn MD, Arthur A.M. Wilde MD PhD, Fleur V.Y. Tjong MD PhD, Reinoud E. Knops MD PhD
Abstract not available
-
Corrigendum to: Abstract 81, Vol 32, Supplement 1, Page S31, (2023) (Abstracts for the Inaugural Tri-Society Cardiac and Thoracic Symposium (3SCTS 2022), 16-19 November 2022, Cairns, Australia) entitled ‘Surgical Management of Ebstein’s Anomaly in Adults’ Heart Lung. Circ. (IF 2.6) Pub Date : 2024-01-28
Abstract not available